Skip to content

Clareon CCWET0 (UDI 00380652405911)Recalls & reported problems

Alcon Laboratories, Inc. · Clareon Vivity UVA · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652405911), received between Jan 18, 2023 and Mar 7, 2023 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Crack” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Crack1
  • Device Dislodged or Dislocated1

Patient problems

  • Blurred Vision1
  • Insufficient Information1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 7, 2023Crack; Crack

    A FACILITY REPRESENTATIVE HAS REPORTED THAT DURING A CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, A LENS UNFOLDED IN THE EYE AND HAD A CRACK AT THE HAPTIC/OPTIC JUNCTION. THE LENS WAS REMOVED DURING SAME PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED, STATING THE SURGEON'S OPINION THAT THE TECHS WERE LEADING THE LENS INCORRECTLY, BUT HE DOES NOT FEEL THAT IT WAS A USER ERROR.

    Patient problems: Insufficient Information

    MAUDE report 16494110 ↗
  • InjuryJan 18, 2023Device Dislodged or Dislocated; Device Dislodged or Dislocated

    AN ADMINISTRATOR REPORTED THAT FOLLOWING A CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED TROUBLE WITH VISUAL ACUITY AND THE CLINICAL REASON WAS LENS WAS MILDLY DISPLACED INFERIORLY AND THERE IS NEGATIVE MOTION TO THE LENS. THE IOL WAS EXCHANGED IN A SECONDARY PROCEDURE FOR ATIOL (ADVANCED TECHNOLOGY INTRAOCULAR LENS). ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision

    MAUDE report 16194009 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page